|
Surgery | N | DRS versus OS | DRS versus LSC | Control | Surgeon | OR time (min.) | EBL (mL) | Hospital stay (days) | Lymph node count | Conversions | Bld Tx | Intraoperative complications | Postoperative complications |
|
Uterine Cancer Staging | | | | | | | | | | | | | |
Veljovich et al. [83] 2006-2007 Swedish Medical CenterSeattle, WA | 25 versus 131 25 versus 4 | ✓ | ✓ | HC + CC Pro-spective HC + CC | DS | 283 versus 139 283 versus 255 | 67 versus 198 67 versus 75 | 1.7 versus 5.3 1.7 versus 1.2 | 18 versus 13 18 versus 20 | DRS: 1 | NR | NR | DRS: Major: 8% Infection (1), cuff dehiscence (1) Minor: 12% OS: Major 21% Cardiac (5), pulmonary (5), renal (4), CVA (1), infection (3), wound dehiscence (9) Minor: 8% LSC: NR |
|
Gehrig et al. [84] 2005–2007 BMI ≥ 30 UNC | 49 versus 32 | | ✓ | HC | NR | 189 versus 215 | 50 versus 150 | 1.0 versus 1.3 | 31 versus 24 | DRS: 0 LSC: 3 | NR | DRS: Enterotomy (1) LSC: none | DRS: Major: 8%port-site hernia (3), cuff complication (1) Minor 2% LSC: Major 6% port-site hernia (1), cuff complication (1) Minor 3% |
|
Boggess et al. [85] 2005–2007 UNC | 103 versus 138 103 versus 81 | ✓ | ✓ | HC HC | DS SS | 191 versus 146 191 versus 213 | 75 versus 266 75 versus 146 | 1 versus 4.4 1 versus 1.2 | 33 versus 15 33 versus 23 | DRS: 2.8% LSC: 3.7% | DRS: 1% OS: 1.4% LSC: 2.5% | DRS: bowel injury (1) OS: enterotomy (1) LSC:caval injury (1), bowel injury (1) | DRS: Major: 2% Port-site hernia (1), PE (1) Minor: 3% OS: Major: 8% CVA (1), ileus + readmission (7), DVT (2), PE (1), respiratory failure (1) Minor: 21% LSC: Major: 5% port-site hernia (1), ileus readmission (1), vaginal dehiscence (1), abscess (1) Minor: 5% |
|
Bell et al. [86] 2005–2007 Sanford Clinic, Sioux Falls, SD | 40 versus 40 40 versus 30 | ✓ | ✓ | HC + CC Retro-spective HC + CC | SS SS | 184 versus 209 184 versus 171 | 166 versus 316 166 versus 253 | 2.3 versus 4.0 2.3 versus 4.0 | 17 versus 14 17 versus 17 | NR | DRS: 5% OS: 15% LSC: 10% | DRS: None OS: genital femoral n. damage (1) LSC: caval injury (1) | DRS: 8% Port-site hernia (1), re-operation for bleeding (1), delayed void (1) OS: 25% Ileus (5), wound infection (2), lymphedema (1), cuff hematoma (1), incisional hernia (1) LSC: 23% Wound infection (3), DVT (1), cuff dehiscence (1), superficial phlebitis (1), A-fib (1) |
|
DeNardis et al. [87] 2006-2007 Florida Hospital Cancer Institute | 56 versus 106 | ✓ | | HC Retro-spective | DS
| 177 versus 79
| 105 versus 241
| 1.0 versus 3.2
| 19 versus 18
| DRS: 5.4%
| 0% versus 9%
| None
| DRS: 20% respiratory failure (1), ileus (1), fever (2), atelectasis (1), wound complication (1), cuff hematoma/separation (4), UTI (1) OS: 61% fever (17), anemia (13), Ileus (4), ARF (2), PE (1), colitis (1), urinary retention (2), thrush (1), UTI (4), atelectasis (4), wound complication (13), lymphocele (1), cuff hematoma/separation (2) |
|
Seamon et al. [88] 2006–2008 OU | 105 versus 76 | | ✓ | HC Pro-spective | SS | 242 versus 287 | 100 versus 250 | 1 versus 2 (med.) | 31 versus 33 | DRS: 12% LSC: 26% | 3% versus 13% | 3 versus 2 DRS: vessel injury (1), GI injury (2) versus OS: nerve injury (1),urinary tract injury (1) | DRS: 9% port-site herniation (1), cardiac (1), pulmonary (1), other (5) LSC: 10% DVT (1), cardiac (1), neurologic (1), other (3) |
|
Seamon et al. [89] 2006 –2008 BMI ≥ 30 OU + UAB Matched: BMI + surgeon 1 : 2 | 109 versus 191 | ✓ | | HC Retro- spective | SS | 228 versus 143 | 109 versus 394 | 1 versus 3 | 25 versus 24 | DRS: 15.6% | 2% versus 9% | 1 versus 2 DRS: GI injury (1) versus OS: vessel injury (1), GI injury (1) | DRS: 10% cardiac (1), pulmonary (2), GI (2), urologic (1), fever (1), fistula (1), bleeding (1), other (3) OS: 26% DVT (1), cardiac (2), pulmonary (2), GI (19), urologic (2), (neurologic (1), fever (4), ARF (3), opiated OD (1), parasthesia (2), arrest (1), death (1)Wound complications: 11% versus 27% |
|
Jung et al. [80] 2006–2009 Korea | 28 versus 56 28 versus 25 | ✓ | ✓ | CC CC Pro-specitve | SS SS | 193 versus 187 193 versus 165 | NR | 7.9 versus 10.8 7.9 versus 7.7 | 21 versus 24 21 versus 18 | none | DRS: 14% OS: 43% LSC: 16% | DRS: none OS: 1 vessel injury LSC: none | DRS: 7% pelvic infection (2) OS: 23% uretral stricture (1), pelvic infection (2), ileus (1), incisional hernia (1), wound dehiscence (6), lymphocele (1), lymphedema (1) LSC: 8% Pelvic infection (2) |
|
Cardenas-Goicoechea et al. [90] 2007–2010 U Penn | 102 versus 173 | | ✓ | HC Retro-spective | SS | 237 versus 178 | 109 versus 187 | 1.9 versus 2.3 | 22 versus 23 | DRS: 1% LSC: 5.2% | 2.9% versus 1.7% | DRS: 2GI injury (2) LSC: 6 Urinary tract injury (6)Higher rates of uretral injury in LSC | DRS: Major (2%) PE (1), enterocutaneous fistula (1) DRS: Minor 8%: lymphocele (1), UTI (2), cuff dehiscence (1), abscess (2), incsional hernia (1), ileus (1) LSC: Major (0%) Minor 8%: lymphocele (3), UTI (1), Pna (2), wound seroma (2), cuff cellulitis (2), SBO (1), hematoma (1), port-site abscess (1) |
|
Lim et al. [91] 2008-2009 Center of HopeReno, Nevada | 56 versus 36 56 versus 56 | ✓ | ✓ | HC HC Pro-spective | SS Initial exp SSInitial exp | 163 versus 137 163 versus 192 | 89 versus 266 89 versus 209 | 1.6 versus 4.9 1.6 versus 2.6 | 27 versus 56 27 versus 45 | DRS: 1.8% LSC:7.1% | DRS: 0% OS: 3% LSC: 0% | DRS: 0OS: 0 LSC: 13% (7) obturator n. injury (3), cystotomy (2), enterotomy (1), vessel injury (1) | DRS: Major: 5% PE (1), abscess (1), perforated gastric ulcer (1) Minor: 9% OS: Major: 14% Abscess/sepsis (1), fistula (1), pna (1), PE (1), hypertensive crisis (1) Minor: 3% LSC: Major: 11% Fistula (1), obturator palsy (3), bacteremia (1), DVT (1) Minor: 4% |
|
Lim et al. [82] 2008–2010 Center of Hope Reno, Nevada | 122 versus 122 | | ✓ | HC Pro-spective | SSInitial ex | 147 versus 187 | 81 versus 207 | 1.5 versus 3.2 | 25 versus 43 | DRS: 0.8% LSC: 6.6% | DRS: 0% LSC: 2.5% | DRS: 0.8% Enterotomy (1) LSC: 6% Obturator n. injury (3), cystotomy (2), enterotomy (1), vessel injury (1) | DRS: Major: 4% PE (1), abscess (1), perforated gastric ulcer (1), bowel perforation (1) Minor: 6% LSC: Major: 10% Fistula (1), obturator palsy (3), bacteremia (1), DVT (1), richter hernia (1), CVA (1) Minor: 2% |
|
Paley et al. [7] 2006–2009 Swedish Medical CenterSeattle, WA | 377 versus 131 | ✓ | | HC Pro-spective | DS | 184 versus 139 | 47 versus 198 | 1.4 versus 5.3 | 16 versus 13 | DRS: 3.5% | DRS: 0.5% OS: 0.8% | DRS: 0.5% Vessel injury (1), cystotomy (1) OS: 3% Uretral injury/ARF | DRS: 5% cardiac (1), pulmonary (3), DVT/PE (3), infection (4), labile bld sugar (2), ileus/SBO (2), chylous ascites (1), cuff dehiscence (4) OS: 17% Cardiac (5), pulmonary (1), DVT/PE (1), infection (6), wound dehiscence (9) |
|